最後更新 2024-05-10 07:07:57 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

-0.3%


截至2023-07-02

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

PerkinElmer, Inc.(柏克萊默公司)在全球提供診斷、生命科學和應用服務市場的產品、服務和解決方案。它通過兩個部門運營,即發現與分析解決方案和診斷部門。發現與分析解決方案部門提供一系列解決方案,包括試劑、信息學和檢測和成像技術,使科學家能夠在生命科學研究市場中提升研究突破,以及合同研究和實驗室服務。它還為環境、食品和工業市場提供分析技術、解決方案和服務,使客戶能夠了解和表徵包括空氣、水和土壤在內的各個方面的健康狀況。此外,該部門還為農民和食品生產商提供解決方案;並為工業市場提供分析儀器,包括化學、半導體和電子、能源、潤滑劑、石化和聚合物行業。診斷部門提供早期檢測遺傳疾病(如懷孕和幼兒期)以及診斷市場中的傳染病檢測的儀器、試劑、分析平台和軟件產品。其產品用於測試和篩查遺傳異常、疾病,包括唐氏綜合症、甲狀腺功能低下症、肌肉萎縮症、不孕症和各種代謝狀況。該部門還開發技術,利用蛋白耦合受體和下一代DNA測序支持基因組工作流程,應用於腫瘤學、免疫診斷和藥物發現。它為製藥和生物技術公司、實驗室、學術和研究機構、公共衛生機構、私人醫療機構、醫生和政府機構提供服務。PerkinElmer, Inc.成立於1937年,總部位於麻薩諸塞州沃爾瑟姆市。

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Diagnostics & Research

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning